TickerFacts.

Heartflow, Inc. (HTFL): R&D Expense

Annual figures by period end, from SEC filings.

$64.92M
Year ended 2025-12-31
$83.84M
Trailing 12 months to 2026-06-30
2023-12-31: $35.85M2024-12-31: $43.52M2025-12-31: $64.92M$64.92M
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$64.92M+49.2%2026-03-18, From 2025-01-01
2024-12-31$43.52M+21.4%2026-03-18, From 2024-01-01
2023-12-31$35.85Mn/a2026-03-18, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Heartflow, Inc. (HTFL)2025-12-31$64.92M+49.2%
SI-BONE, Inc. (SIBN)2025-12-31$17.45M+5.4%
Neuronetics, Inc. (STIM)2025-12-31$6.58M-48.4%
Treace Medical Concepts, Inc. (TMCI)2025-12-31$20.28M-1.5%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$2.10M-11.9%
Cerus Corp (CERS)2025-12-31$67.72M+15.0%
Orthopediatrics Corp (KIDS)2025-12-31$9.10M-17.5%
Lemaitre Vascular Inc (LMAT)2025-12-31$14.14M-9.7%
Orasure Technologies Inc (OSUR)2025-12-31$42.53M+63.3%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗